Kausik Ray FESC is Professor of Public Heath, Director of the Imperial Centre for CVD Prevention, Deputy Director of Imperial Clinical Trials Unit and Head of Commercial Trials Imperial College London and Consultant Cardiologist. He received his medical education Birmingham Univ, MD from Sheffield Univ, a fellowship at Harvard Medical School and finally an MPhil in Epidemiology at Cambridge Univ. He is current president of the EAS and national CVD prevention lead for the NIHR ARC. Professor Ray: is the lead for the 70 country FH Studies Collaboration the only global registry of FH, PI for the TOGETHER study looking at cardiometabolic risk in the vascular health checks in 250,000 people in London. Professor Ray has led and participated in several novel therapies for hypercholesterolaemia and diabetes. Voted by Clarivate as among the top 1% of authors cited in clinical medicine globally H Index 84, i10 218 and ~ 90,000 citations.
